1. Ginsenoside G-Rh2 synergizes with SMI-4a in anti-melanoma activity through autophagic cell death
   Da-lun Lv et al, 2018, Chin Med CrossRef
2. Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with BRAF Mutation
   Min Song Suh et al, 2018, Ann Dermatol CrossRef
3. Detection of BRAFV600E Mutation in Melanoma Patients by Digital PCR of Circulating DNA
   Tatiana Burjanivova et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
4. CX-F9, a Novel RSK2 Inhibitor, suppresses Cutaneous Melanoma Cells Proliferation and Metastasis through regulating Autophagy
   Xu Zhang et al, 2019, Biochemical Pharmacology CrossRef
5. Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
   Parvez M. Lokhandwala et al, 2019, BMC Cancer CrossRef
6. Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma
   Christopher S. Hong et al, 2020, npj Genom. Med. CrossRef
7. PTMsnp: A Web Server for the Identification of Driver Mutations That Affect Protein Post-translational Modification
   Di Peng et al, 2020, Front. Cell Dev. Biol. CrossRef
8. Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
   Magdalena Śmiech et al, 2020, Genes CrossRef
9. BRAF Gene and Melanoma: Back to the Future
   Margaret Ottaviano et al, 2021, IJMS CrossRef
10. BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes.
    Mina Nikanjam et al, 2021, Mol Cancer Ther CrossRef
11. BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
    Laure Moisset et al, 2019, Case Rep Oncol CrossRef
12. Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
    Qi Wan et al, 2022, Front. Immunol. CrossRef
13. Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal
    Filipa Alves da Costa et al, 2023, Sci Rep CrossRef
14. Interactome dynamics of RAF1-BRAF kinase monomers and dimers
    Luis F. Iglesias-Martinez et al, 2023, Sci Data CrossRef
15. Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
    Alexandra M. Haugh et al, 2024, Cancers CrossRef
16. Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma
    Paweł Kozyra et al, 2024, CMC CrossRef
17. The Efficacy of Curcumin Application to Melanoma in Mice
    Liqun Teng et al, 2024, Ann Plast Surg CrossRef
18. Therapeutic advances of targeting receptor tyrosine kinases in cancer
    Ciprian Tomuleasa et al, 2024, Sig Transduct Target Ther CrossRef
19. The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
    Tara M. Hosseini et al, 2024, Cancers CrossRef
20. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
    S. Afsar et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
21. Elucidation of anti-human melanoma and anti-aging mechanisms of compounds from green seaweed Caulerpa racemosa
    Danar Wicaksono et al, 2024, Sci Rep CrossRef